Enterprise Therapeutics Ltd
3 clinical trials · Sponsor
◉ Watch Enterprise Therapeutics Ltd
| Record | Firm | Date |
|---|---|---|
| A Two-Part Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of Repeat Doses of Inhaled ETD001 in People With Cystic Fibrosis (NCT06478706) | Enterprise Therapeutics Ltd | 2024-06-26 |
| A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD001 in Healthy Subjects (NCT04926701) | Enterprise Therapeutics Ltd | 2021-06-11 |
| A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD002 in Healthy Subjects (NCT04488705) | Enterprise Therapeutics Ltd | 2020-08-13 |
Track Enterprise Therapeutics Ltd automatically
Every clearance here is in the API, with alerts when new ones post.